LEXARIA BIOSCIENCE CORP. Cash and Cash Equivalents, Period Increase (Decrease)
LEXARIA BIOSCIENCE CORP. (LEXX) reported Cash and Cash Equivalents, Period Increase (Decrease) of $9.62 million for the 12-month period ending 2021-08-31, per its 10-K filed 2021-11-29.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-11-29
- LEXARIA BIOSCIENCE CORP. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-08-31 was $2.81M.
- LEXARIA BIOSCIENCE CORP. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-05-31 was -$1.24M, a 195.70% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-02-28 was $8.82M.
- LEXARIA BIOSCIENCE CORP. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-11-30 was -$768.41K, a 1695.07% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. cash and cash equivalents, period increase (decrease) for fiscal 2021 was $9.62M, a 111781.52% increase from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. cash and cash equivalents, period increase (decrease) for fiscal 2020 was $8.60K.
- LEXARIA BIOSCIENCE CORP. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$442.04K.
- LEXARIA BIOSCIENCE CORP. cash and cash equivalents, period increase (decrease) for fiscal 2018 was -$806.15K, a 133.04% decline from fiscal 2017.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 10 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month |
|---|---|---|---|---|---|---|---|
| 2021-08-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $1.57M derived: sum of 2 quarters · filed 2021-11-29 | $10.39M derived: sum of 3 quarters · filed 2021-11-29 | $9.62M 10-K · filed 2021-11-29 | |||
| 2021-05-31 | -$1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | $7.58M derived: sum of 2 quarters · filed 2021-07-15 | $6.81M 10-Q · filed 2021-07-15 | $6.07M derived: sum of 4 quarters · filed 2021-11-29 | |||
| 2021-02-28 | $8.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | $8.05M 10-Q · filed 2021-04-14 | $7.31M derived: sum of 3 quarters · filed 2021-11-29 | $8.61M derived: sum of 4 quarters · filed 2021-11-29 | |||
| 2020-11-30 | -$768.41K 10-Q · filed 2021-01-14 | -$1.51M derived: sum of 2 quarters · filed 2021-11-29 | -$214.64K derived: sum of 3 quarters · filed 2021-11-29 | -$807.98K derived: sum of 4 quarters · filed 2021-11-29 | |||
| 2020-08-31 | -$740.26K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-29 | $553.76K derived: sum of 2 quarters · filed 2021-11-29 | -$39.57K derived: sum of 3 quarters · filed 2021-11-29 | $8.60K 10-K · filed 2021-11-29 | |||
| 2020-05-31 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-07-15 | $700.69K derived: sum of 2 quarters · filed 2021-07-15 | $748.86K 10-Q · filed 2021-07-15 | $38.17K derived: sum of 4 quarters · filed 2021-07-15 | |||
| 2020-02-29 | -$593.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-04-14 | -$545.16K 10-Q · filed 2021-04-14 | -$1.26M derived: sum of 3 quarters · filed 2021-04-14 | -$2.35M derived: sum of 4 quarters · filed 2021-04-14 | |||
| 2019-11-30 | $48.17K 10-Q · filed 2021-01-14 | -$662.52K derived: sum of 2 quarters · filed 2021-01-14 | -$1.76M derived: sum of 3 quarters · filed 2021-01-14 | -$1.31M derived: sum of 4 quarters · filed 2021-01-14 | |||
| 2019-08-31 | -$710.70K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | -$1.81M derived: sum of 2 quarters · filed 2020-10-15 | -$1.36M derived: sum of 3 quarters · filed 2020-10-15 | -$442.04K 10-K · filed 2020-10-15 | |||
| 2019-05-31 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-06-29 | -$649.02K derived: sum of 2 quarters · filed 2020-06-29 | $268.66K 10-Q · filed 2020-06-29 | $268.66K 10-Q · filed 2019-07-08 | -$67.53K derived: sum of 4 quarters · filed 2020-06-29 | ||
| 2019-02-28 | $448.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-04-03 | $1.37M 10-Q · filed 2020-04-03 | $1.03M derived: sum of 3 quarters · filed 2020-04-03 | $775.52K derived: sum of 4 quarters · filed 2020-04-03 | |||
| 2018-11-30 | $917.68K 10-Q · filed 2020-01-09 | $581.49K derived: sum of 2 quarters · filed 2020-01-09 | $327.17K derived: sum of 3 quarters · filed 2020-01-09 | $435.16K derived: sum of 4 quarters · filed 2020-01-09 | |||
| 2018-08-31 | -$336.19K derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-14 | -$590.51K derived: sum of 2 quarters · filed 2019-11-14 | -$482.52K derived: sum of 3 quarters · filed 2019-11-14 | -$806.15K 10-K · filed 2019-11-14 | |||
| 2018-05-31 | -$254.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-07-08 | -$146.33K derived: sum of 2 quarters · filed 2019-07-08 | -$469.97K 10-Q · filed 2019-07-08 | -$725.61K derived: sum of 4 quarters · filed 2019-07-08 | |||
| 2018-02-28 | $107.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-04-15 | -$215.64K 10-Q · filed 2019-04-15 | -$471.28K derived: sum of 3 quarters · filed 2019-04-15 | $1.79M derived: sum of 4 quarters · filed 2019-04-15 | |||
| 2017-11-30 | -$323.63K 10-Q · filed 2019-01-11 | -$579.27K derived: sum of 2 quarters · filed 2019-01-11 | $1.69M derived: sum of 3 quarters · filed 2019-01-11 | $2.09M derived: sum of 4 quarters · filed 2019-01-11 | |||
| 2017-08-31 | -$255.64K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $2.01M derived: sum of 2 quarters · filed 2018-11-14 | $2.41M derived: sum of 3 quarters · filed 2018-11-14 | $2.44M 10-K · filed 2018-11-14 | |||
| 2017-05-31 | $2.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $2.66M derived: sum of 2 quarters · filed 2018-07-13 | $2.70M 10-Q · filed 2018-07-13 | $2.75M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-02-28 | $399.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $430.22K 10-Q · filed 2018-04-12 | $486.53K derived: sum of 3 quarters · filed 2018-11-14 | ||||
| 2016-11-30 | $30.84K 10-Q · filed 2018-01-12 | $87.14K derived: sum of 2 quarters · filed 2018-11-14 | |||||
| 2016-08-31 | $56.31K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | -$166.67K 10-K · filed 2018-11-14 | |||||
| 2016-05-31 | -$222.97K 10-Q · filed 2017-07-14 | ||||||
| 2016-02-29 | -$219.85K 10-Q · filed 2017-04-14 | ||||||
| 2015-11-30 | -$176.04K 10-Q · filed 2017-01-13 | -$748.07K derived: sum of 2 quarters · filed 2017-01-13 | |||||
| 2015-08-31 | -$572.03K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | -$442.95K 10-K · filed 2016-11-29 | |||||
| 2015-05-31 | $129.07K 10-Q · filed 2016-07-13 | ||||||
| 2015-02-28 | $88.99K 10-Q · filed 2016-04-13 | $88.99K 10-Q · filed 2015-04-14 | |||||
| 2014-11-30 | -$271.96K 10-Q · filed 2016-01-08 | -$446.81K derived: sum of 2 quarters · filed 2016-01-08 | |||||
| 2014-08-31 | -$174.86K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $637.49K 10-KT · filed 2014-12-09 | $637.49K 10-K · filed 2015-11-27 | ||||
| 2014-07-31 | -$373.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $549.82K derived: sum of 2 quarters · filed 2014-11-14 | $512.93K 10-Q · filed 2014-11-14 | ||||
| 2014-05-31 | $812.34K 10-Q · filed 2015-07-14 | ||||||
| 2014-04-30 | $923.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | $886.20K 10-Q · filed 2014-06-12 | |||||
| 2014-02-28 | -$28.64K 10-Q · filed 2015-04-14 | ||||||
| 2014-01-31 | -$36.89K 10-Q · filed 2014-03-12 | ||||||
| 2013-11-30 | $59.65K 10-Q · filed 2015-01-14 | ||||||
| 2013-10-31 | $38.01K derived: 10-KT 12 month − 10-Q 9 month · filed 2014-12-09 | $21.01K derived: sum of 2 quarters · filed 2014-12-09 | $26.61K derived: sum of 3 quarters · filed 2014-12-09 | -$114.97K 10-KT · filed 2014-12-09 | |||
| 2013-08-31 | -$141.61K 10-KT · filed 2014-12-09 | ||||||
| 2013-07-31 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$11.41K derived: sum of 2 quarters · filed 2014-11-14 | -$152.99K 10-Q · filed 2014-11-14 | $11.08K derived: sum of 4 quarters · filed 2014-11-14 | |||
| 2013-04-30 | $5.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | -$135.99K 10-Q · filed 2014-06-12 | $28.08K derived: sum of 3 quarters · filed 2014-06-12 | -$76.03K derived: sum of 4 quarters · filed 2014-06-12 | |||
| 2013-01-31 | -$141.58K 10-Q · filed 2014-03-12 | $22.49K derived: sum of 2 quarters · filed 2014-03-12 | -$81.62K derived: sum of 3 quarters · filed 2014-03-12 | -$101.55K derived: sum of 4 quarters · filed 2014-03-12 | |||
| 2012-10-31 | $164.07K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $59.95K derived: sum of 2 quarters · filed 2014-01-24 | $40.03K derived: sum of 3 quarters · filed 2014-01-24 | $149.31K 10-K · filed 2014-01-24 | |||
| 2012-07-31 | -$104.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-10 | -$124.04K derived: sum of 2 quarters · filed 2013-09-10 | -$14.76K 10-Q · filed 2013-09-10 | -$478.00K derived: sum of 4 quarters · filed 2013-09-10 | |||
| 2012-04-30 | -$19.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-12 | $89.36K 10-Q · filed 2013-06-12 | -$373.88K derived: sum of 3 quarters · filed 2013-06-12 | -$6.28K derived: sum of 4 quarters · filed 2013-06-12 | |||
| 2012-01-31 | $109.28K 10-Q · filed 2013-03-13 | -$353.96K derived: sum of 2 quarters · filed 2013-03-13 | $13.65K derived: sum of 3 quarters · filed 2013-03-13 | -$139.11K derived: sum of 4 quarters · filed 2013-03-13 | |||
| 2011-10-31 | -$463.24K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | -$95.64K derived: sum of 2 quarters · filed 2013-01-29 | -$248.40K derived: sum of 3 quarters · filed 2013-01-29 | -$31.79K 10-K · filed 2013-01-29 | |||
| 2011-07-31 | $367.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-12 | $214.85K derived: sum of 2 quarters · filed 2012-09-12 | $431.45K 10-Q · filed 2012-09-12 | $63.05K derived: sum of 4 quarters · filed 2012-09-12 | |||
| 2011-04-30 | -$152.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-07 | $63.85K 10-Q · filed 2012-06-07 | -$304.56K derived: sum of 3 quarters · filed 2012-06-07 | ||||
| 2011-01-31 | $216.61K 10-Q · filed 2012-03-13 | -$151.80K derived: sum of 2 quarters · filed 2012-03-13 | |||||
| 2010-10-31 | -$368.40K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | -$267.18K 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $101.23K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |